List | Section | Observation |
---|---|---|
Bolivia | LINAME 2011 - 2013 | No observations |
Peru | 8.1 Immunosuppressives | No observations |
Chile | Essential and Prioritized Medications | No observations |
Cuba | 8.1 Inmunosupresores | No observations |
WHO Model List of Essential Medicines (2021) | 8.1 Immunomodulators for non-malignant disease |
Others observations: Immediate release |
List | Section | Observation |
---|---|---|
Cuba | 8.1 Inmunosupresores | No observations |
WHO Model List of Essential Medicines (2021) | 8.1 Immunomodulators for non-malignant disease |
Others observations: Immediate Release |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 8.1 Immunomodulators for non-malignant disease |
Others observations: Immediate release |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 8.1 Immunomodulators for non-malignant disease |
Others observations: Immediate release |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 8.1 Immunomodulators for non-malignant disease |
Others observations: Immediate release |
List | Section | Observation |
---|---|---|
PAHO Strategic Fund Medicine List | 3.1. Immunosuppressive Agents | No observations |
List | Section | Observation |
---|---|---|
PAHO Strategic Fund Medicine List | 3.1. Immunosuppressive Agents | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 8.1 Immunomodulators for non-malignant disease | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 8.1 Immunomodulators for non-malignant disease | No observations |
List | Section | Observation |
---|---|---|
Peru | 8.1 Immunosuppressives | No observations |
WHO Model List of Essential Medicines (2021) | 8.1 Immunomodulators for non-malignant disease | No observations |
List | Section | Observation |
---|---|---|
Peru | 8.1 Immunosuppressives | No observations |